Pancreatic Cancer Clinical Trials

Showing 481-500 of 565 trials

Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer

NCT00548626

The aim of this study is to evaluate if the early change of needle during EUS-FNA for suspected pancreatic cancer allows an earlier preliminary cytological diagnosis of neoplasia.

Pancreatic Cancer

University of Chicago47 participantsStarted Oct 2007

Chicago, Illinois, United States

COMPLETED

B-Receptor Signaling in Cardiomyopathy

NCT01135849

We hope to determine the importance of different genes (including B receptors) in anthracycline-induced cardiomyopathy. This has important benefits to patients exposed to anthracyclines, as this could help determine whether certain individuals have increased susceptibility to cardiac injury.

CarcinomasAmyloidosisAnal Cancer+35 more

Daniel Bernstein99 participantsStarted Nov 2008

Stanford, California, United States

COMPLETED

Ghrelin Levels in Pancreatic Cancer Patients

NCT00225745

The primary outcome measure for this study is plasma ghrelin level.

Pancreatic Cancer

Dartmouth-Hitchcock Medical Center72 participantsStarted Apr 2004

Lebanon, New Hampshire, United States

Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer

B-Receptor Signaling in Cardiomyopathy

Ghrelin Levels in Pancreatic Cancer Patients

Related Searches

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Perifosine in Treating Patients With Advanced Pancreatic Cancer

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation

The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer

Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

EGF Ointment for Erlotinib Skin Lesion

Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study

Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery